Breaking News Instant updates and real-time market news.

ZAGG

Zagg

$7.53 /

+0.03 (+0.40%)

, TESS

Tessco

$10.39 /

+0.24 (+2.36%)

08:13
01/16/20
01/16
08:13
01/16/20
08:13

InvisibleShield signs exclusive distribution partnership with Tessco

InvisibleShield, a ZAGG Brands (ZAGG) company, announced an exclusive partnership with TESSCO Technologies (TESS) to distribute InvisibleShield On Demand to more than 20,000 brick-and mortar retail stores throughout the U.S.

ZAGG

Zagg

$7.53 /

+0.03 (+0.40%)

TESS

Tessco

$10.39 /

+0.24 (+2.36%)

  • 28

    Jan

ZAGG Zagg
$7.53 /

+0.03 (+0.40%)

03/13/19 DADA
Zagg shares still attractively valued, says DA Davidson
08/07/19 CHLM
Zagg price target lowered to $12 from $17.50 at Craig-Hallum
TESS Tessco
$10.39 /

+0.24 (+2.36%)

TODAY'S FREE FLY STORIES

Hot Stocks
Soliton announces study results using RAP Device » 08:05
01/27/20
01/27
08:05
01/27/20
08:05
SOLY

Soliton

$14.68 /

-0.49 (-3.23%)

Soliton announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Lakeland Financial board reauthorizes stock repurchase up to $30M » 08:05
01/27/20
01/27
08:05
01/27/20
08:05
LKFN

Lakeland Financial

$47.69 /

-0.29 (-0.60%)

In addition, on January…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Sprint reports postpaid gross additions in digital channels up 80% y/y » 08:05
01/27/20
01/27
08:05
01/27/20
08:05
S

Sprint

$4.83 /

-0.2 (-3.98%)

In Q3: Postpaid gross…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Applied Therapeutics price target raised to $65 from $20 at UBS » 08:04
01/27/20
01/27
08:04
01/27/20
08:04
APLT

Applied Therapeutics

$48.65 /

-0.315 (-0.64%)

UBS analyst Navin Jacob…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Lakeland Financial approves cash dividend of 30c for Q4 » 08:04
01/27/20
01/27
08:04
01/27/20
08:04
LKFN

Lakeland Financial

$47.69 /

-0.29 (-0.60%)

As announced on January…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
UBS to hold a tour and field trip » 08:04
01/27/20
01/27
08:04
01/27/20
08:04

Winter MLP & Natural…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
Lakeland Financial reports Q4 EPS 86c, consensus 77c » 08:03
01/27/20
01/27
08:03
01/27/20
08:03
LKFN

Lakeland Financial

$47.69 /

-0.29 (-0.60%)

David Findlay, President…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Sprint reports Q3 postpaid wireless service revenue $4.2B » 08:03
01/27/20
01/27
08:03
01/27/20
08:03
S

Sprint

$4.83 /

-0.2 (-3.98%)

Postpaid wireless service…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Select Medical sees FY20 EPS $1.27-$1.46, consensus $1.33 » 08:03
01/27/20
01/27
08:03
01/27/20
08:03
SEM

Select Medical

$23.87 /

-0.62 (-2.53%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Jefferies starts Elbit Systems at Buy with $185 price target » 08:02
01/27/20
01/27
08:02
01/27/20
08:02
ESLT

Elbit Systems

$153.84 /

-0.11 (-0.07%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Commodity Markets Council to hold a conference » 08:02
01/27/20
01/27
08:02
01/27/20
08:02
CME

CME Group

$209.27 /

+1.02 (+0.49%)

, ICE

IntercontinentalExchange

$97.11 /

-0.2 (-0.21%)

State of the Industry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Piper Sandler to host company meetings at conference » 08:01
01/27/20
01/27
08:01
01/27/20
08:01
LEG

Leggett & Platt

$50.90 /

-0.4 (-0.78%)

, TPX

Tempur Sealy

$87.31 /

-0.73 (-0.83%)

Piper Sandler Hosted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Sprint reports Q3 EPS (3c), consensus (5c) » 08:01
01/27/20
01/27
08:01
01/27/20
08:01
S

Sprint

$4.83 /

-0.2 (-3.98%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Korn/Ferry management to meet with Sidoti » 08:01
01/27/20
01/27
08:01
01/27/20
08:01
KFY

Korn/Ferry

$43.03 /

-0.59 (-1.35%)

Meeting to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Canaccord upgrades Biogen to Buy on 'decent shot' of Alzheimer's approval » 08:01
01/27/20
01/27
08:01
01/27/20
08:01
BIIB

Biogen

$278.14 /

-6.11 (-2.15%)

Canaccord Genuity analyst…

Canaccord Genuity analyst Sumant Kulkarni upgraded Biogen to Buy from Hold with a price target of $360, up from $305. The shares closed Friday down 2% to $278.14. The analyst admits to being "surprised as anyone" by Biogen's "sudden revival" in October of aducanumab for early Alzheimer's disease. Kulkarni, who retains a "healthy degree of skepticism" around the trial data Biogen presented in December, says that even skeptics appear to agree that aducanumab, "for a variety of reasons, has a decent shot at FDA approval." This is not reflected in the shares at current levels, Kulkarni tells investors in a research note. The analyst likes the opportunity Biogen presents heading into the "regulatory saga" on aducanumab. His new price target reflects a 50% probability of approval for aducanumab.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Deckers Brands sentiment remains positive, says Baird » 08:01
01/27/20
01/27
08:01
01/27/20
08:01
DECK

Deckers Brands

$177.84 /

+2.75 (+1.57%)

Baird analyst Jonathan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Drug Information Association to hold a conference » 08:00
01/27/20
01/27
08:00
01/27/20
08:00
ABBV

AbbVie

$83.53 /

-1.73 (-2.03%)

, ALLO

Allogene Therapeutics

$23.43 /

-1.29 (-5.22%)

, ALXN

Alexion

$105.24 /

-3.3 (-3.04%)

, BMY

Bristol-Myers

$64.18 /

-2.715 (-4.06%)

, CELG

Bought by BMY

$0.00 /

+ (+0.00%)

, CRBP

Corbus Pharmaceuticals

$6.73 /

-0.29 (-4.13%)

, ESALY

Eisai

$0.00 /

+ (+0.00%)

, EXPO

Exponent

$72.45 /

-0.9 (-1.23%)

, GSK

GlaxoSmithKline

$47.24 /

-0.605 (-1.26%)

, HALO

Halozyme

$19.07 /

-0.58 (-2.95%)

, IQV

Iqvia

$158.14 /

-2.735 (-1.70%)

, LLY

Eli Lilly

$139.09 /

-2.14 (-1.52%)

, PFE

Pfizer

$39.82 /

-0.89 (-2.19%)

Pharmacovigilance &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
FTC grants early termination of HSR Act waiting period for Achillion sale » 08:00
01/27/20
01/27
08:00
01/27/20
08:00
ACHN

Achillion

$6.14 /

-0.025 (-0.41%)

, ALXN

Alexion

$105.24 /

-3.3 (-3.04%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Apple put buyer realizes 34% same-day gains » 08:00
01/27/20
01/27
08:00
01/27/20
08:00
AAPL

Apple

$318.25 /

-1.02 (-0.32%)

Notable profits for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
BBX Capital management to meet with Sidoti » 07:59
01/27/20
01/27
07:59
01/27/20
07:59
BBX

BBX Capital

$4.07 /

-0.05 (-1.21%)

Meeting to be held in New…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
American Hotel & Lodging Association to hold a summit » 07:59
01/27/20
01/27
07:59
01/27/20
07:59
AAL

American Airlines

$27.66 /

-1.14 (-3.96%)

, ACCYY

Accor

$0.00 /

+ (+0.00%)

, CBRE

CBRE Group

$60.78 /

-0.065 (-0.11%)

, DRH

DiamondRock

$10.13 /

-0.305 (-2.92%)

, PEB

Pebblebrook Hotel

$24.64 /

-0.455 (-1.81%)

, WH

Wyndham Hotels & Resorts

$58.58 /

-0.84 (-1.41%)

Americas Lodging…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Jefferies starts Relmada at Buy, sees 50-100% upside potential » 07:58
01/27/20
01/27
07:58
01/27/20
07:58
RLMD

Relmada Therapeutics

$43.00 /

+2.5 (+6.17%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
International Market Centers to hold a conference » 07:58
01/27/20
01/27
07:58
01/27/20
07:58

2020 Winter Las Vegas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Goldman Sachs to host investor day » 07:58
01/27/20
01/27
07:58
01/27/20
07:58
GS

Goldman Sachs

$241.87 /

-3.78 (-1.54%)

Investor day to be held…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Coronavirus could be 3%-5% EPS hit for China-exposed stocks, says Credit Suisse » 07:56
01/27/20
01/27
07:56
01/27/20
07:56
EL

Estee Lauder

$205.32 /

-3.47 (-1.66%)

, NKE

Nike

$102.03 /

-0.98 (-0.95%)

, TPR

Tapestry

$27.29 /

-0.635 (-2.27%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.